| Parameters |
Group |
I |
II |
III |
IV |
| Dose |
0 mg/kg |
750 mg/kg |
400 mg/kg |
400+750
mg/kg |
Absolute Total Fetal
B. wt (g) |
Mean |
35.21 |
29.00 |
36.38 |
35.21 |
| SD |
12.72 |
11.69 |
5.92 |
12.32 |
| n |
9 |
9 |
8 |
9 |
| Placenta wt. (g) |
Mean |
0.43 |
0.43 |
0.38 |
0.45 |
| SD |
0.06 |
0.04 |
0.03 |
0.07 |
| n |
9 |
9 |
8 |
9 |
| Crown-rump length (cm) |
Mean |
3.22 |
3.20 |
2.99 |
3.27 |
| SD |
0.10 |
0.28 |
0.24 |
0.15 |
| n |
9 |
9 |
8 |
9 |
| Average Total Fetal B. wt (g) |
Mean |
3.51 |
3.56 |
3.50 |
3.60 |
| SD |
0.32 |
0.51 |
0.16 |
0.17 |
| n |
9 |
9 |
8 |
9 |
| Average Male Fetal B. wt (g) |
Mean |
3.58 |
3.57 |
3.53 |
3.64 |
| SD |
0.39 |
0.56 |
0.18 |
0.20 |
| n |
9 |
8 |
8 |
9 |
| Average Female Fetal B. wt (g) |
Mean |
3.38 |
3.57 |
3.46 |
3.55 |
| SD |
0.51 |
0.48 |
0.15 |
0.15 |
| n |
8 |
9 |
8 |
9 |
Group I : Control Group II: β Cyclodextrin, III: Tolbutamide IV: β Cyclodextrin + tolbutamide. |